元旦"微度假"热度高 [Table_Authors] 李林芷(分析师) 国内高频指标跟踪（2026 年第 1 期） 本报告导读： 消费复苏动能较强，但投资、生产仍需政策进一步提振。 投资要点： | | 021-23185646 | | --- | --- | | | lilinzhi2@gtht.com | | 登记编号 | S0880525040087 | | | 邵睿思(研究助理) | | | 010-83939827 | | | shaoruisi@gtht.com | | 登记编号 | S0880125070011 | | | 应镓娴(分析师) | | | 021-23185645 | | | yingjiaxian@gtht.com | | 登记编号 | S0880525040060 | | | 梁中华(分析师) | | | 021-23219820 | | | liangzhonghua@gtht.com | | 登记编号 | S0880525040019 | [Table_Report] 相关报告 金银铜续创新高，人民币汇率破 7 2025.12.28 消费温和改善 2025.12.28 内需有 ...

Investment Rating - The report assigns a rating of "Buy" for the company [4]. Core Insights - The report highlights a rich pipeline for the company in 2026, with expectations for significant clinical data readouts, including results for HER2 ADC, B7H3 ADC, and TROP2 ADC [12][19]. - The target price for the company has been raised to HKD 455.56 based on DCF valuation methods, reflecting increased confidence in the potential global sales peak for several ADC products [8][12]. Financial Summary - Total revenue is projected to grow from RMB 1,462 million in 2023 to RMB 2,516 million by 2027, with a notable increase of 23% in 2026 [3]. - Gross profit margin is expected to improve from 34% in 2025 to 51% in 2027, indicating a positive trend in profitability [3]. - Net profit is forecasted to decrease from RMB -757 million in 2025 to RMB -321 million in 2027, showing a gradual reduction in losses [3]. Pipeline Developments - HER2 ADC DB1303 is undergoing global registration clinical trials for multiple indications, with expected results in 2026 [12][11]. - B7H3 ADC DB1311 is anticipated to initiate a global Phase III clinical trial for 2L CRPC in 2026, following promising data from earlier studies [13][12]. - TROP2 ADC DB1305 is expected to demonstrate comparable efficacy to competitors in the market, with a focus on combination therapies [19][21]. Market Position - The company is positioned to compete effectively in the ADC market, with a strong emphasis on innovative therapies and strategic partnerships [12][19]. - The report notes the potential for the company's ADCs to become next-generation standard treatments in oncology, particularly in combination with other therapies [12][19].

Investment Rating - The report assigns an "Accumulate" rating for the dairy industry, indicating a positive outlook for investment opportunities [5]. Core Insights - The report highlights that the stabilization of raw milk prices and the expected upward trend in 2026 are driven by the reduction in supply-side expansion and decreased breeding stock, alongside the release of processing capacity on the demand side. The domestic beef demand is anticipated to be boosted by the implementation of import beef safeguard policies, leading to a sustained upward cycle in the beef industry [2][4]. Summary by Sections Investment Recommendations - The report suggests that the dairy industry will benefit from the easing of supply-side pressures and a reduction in breeding stock, with a strong likelihood of an upward trend in profitability for leading companies such as YouRan Dairy and Modern Farming [4][7]. Import Beef Safeguard Measures - The report details that starting January 1, 2026, a 55% tariff will be imposed on beef imports outside of the quota, with a nearly 6% reduction in quotas for major supplying countries. This policy is expected to enhance domestic beef demand and support the beef industry's growth cycle [2][4]. Beef Import Data - In 2024, the total beef import volume was 2.87 million tons, with Brazil, Argentina, and Australia being the largest suppliers, accounting for over 93% of imports. The report notes a projected decrease of 5.7% in quotas for 2026 compared to the previous 12 months, with significant reductions for Brazil and Australia [6][4]. Profit Forecast and Valuation - The report provides earnings per share (EPS) forecasts for key companies, with YouRan Dairy expected to achieve an EPS of 0.33 yuan in 2026, and Modern Farming projected to reach 0.05 yuan. The price-to-earnings (PE) ratios for these companies are also discussed, indicating a favorable valuation outlook [7].

新店型、新周期 巴比食品(605338) ——公司跟踪报告 | [姓名table_Authors] | 电话 | 邮箱 | 登记编号 | | --- | --- | --- | --- | | 訾猛(分析师) | 021-38676442 | zimeng@gtht.com | S0880513120002 | | 颜慧菁(分析师) | 021-23183952 | yanhuijing@gtht.com | S0880525040022 | | 程碧升(分析师) | 021-23185685 | chengbisheng@gtht.com | S0880525040031 | | 陈力宇(分析师) | 021-38677618 | chenliyu@gtht.com | S0880522090005 | 本报告导读： 小笼包新店型的开店速度有望超预期，竞争担忧短期无虞，打开成长新周期。 投资要点： | [Table_Finance] 财务摘要(百万元) | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- ...

Group 1 - The report highlights that the bond market experienced significant volatility at the end of 2025, with a notable increase in trading volume contrary to typical year-end trends, indicating a dominant position of short positions and profit-taking strategies [7][8]. - The report identifies two main reasons for the observed market behavior: persistent bearish sentiment and speculative trading strategies that exploit low trading volumes to create market fluctuations [8][9]. - It suggests that in a low-interest-rate and high-volatility environment, such phenomena are likely to increase, recommending two strategies for investors: hedging strategies for those seeking to smooth volatility and reverse trading strategies for those looking to capitalize on price corrections [9][11]. Group 2 - The report discusses the outlook for government bond futures, indicating that the cost-effectiveness of positive spread strategies is currently low due to a significant bearish sentiment, with IRR values for main contracts showing a decline [16]. - It emphasizes the importance of monitoring long-end basis convergence opportunities, as recent market conditions have led to a widening of basis spreads, suggesting potential for mean reversion [19]. - The report notes limited short-term trading opportunities in cross-period strategies due to consistent price movements across contracts, recommending a cautious approach [21]. Group 3 - The report outlines a curve strategy that suggests potential for flat trading opportunities post-holiday, as the long-end and ultra-long-end segments have shown significant declines, indicating a possible rebound [24].

Investment Rating - The industry investment rating is "Increase" [2][18] Core Insights - The report indicates that the real estate market has shown mixed results in transaction volumes, with a stable and fluctuating trend expected to continue due to ongoing accommodative policies [2][3] - The report anticipates that the policy environment will remain supportive, which will help stabilize the market in 2026 [3] Summary by Sections Transaction Data - In the first week of 2026, the new housing transaction area in 30 major cities was 3.15 million square meters, a week-on-week increase of 5.2% but a year-on-year decrease of 20.6% [3] - First-tier cities saw a sales area of 710,000 square meters, up 31.0% week-on-week but down 24% year-on-year [3] - Second-tier cities recorded a sales area of 1.98 million square meters, a week-on-week increase of 2.83% and a year-on-year decrease of 15% [3] - Third-tier cities had a sales area of 470,000 square meters, down 12.3% week-on-week and down 34.5% year-on-year [3] Cumulative Transaction Data - As of January 1, 2026, the cumulative transaction area in 30 cities was 90,000 square meters, down 61.8% year-on-year [3] - Cumulative transaction areas for first-tier, second-tier, and third-tier cities were 30,000 square meters, 40,000 square meters, and 10,000 square meters respectively, with significant year-on-year declines [3] Land Transaction Data - The land supply area was 1.028 million square meters, with a transaction area of 3.33 million square meters, resulting in a supply-to-sales ratio of 0.31 [3] - The total land transfer amount was 121.8 billion yuan, with a year-on-year decrease of 15.9% [3] Inventory and Clearance Cycle - The inventory clearance cycle in 35 cities increased to 24.54 months, up 6.64% month-on-month and down 12.09% year-on-year [3]

Investment Rating - The report rates the construction industry as "Buy" [1] Core Insights - The National Development and Reform Commission has announced a significant investment plan for 2026, with a total of approximately 295 billion yuan allocated for major infrastructure projects, including the Guangzhou New Airport and the Zhanjiang to Haikou ferry project, with total investments exceeding 400 billion yuan [4][3] - The report emphasizes the orderly expansion of low-altitude economic application scenarios, with significant progress expected in housing quality improvement by 2030 [4][3] - The report recommends several companies in emerging sectors such as clean rooms, commercial aerospace, and controlled nuclear fusion, highlighting specific stocks like Yaxiang Integration and China Nuclear Engineering [4][6] Summary by Sections Recent Key Reports - The report discusses the need for high-demand, high-barrier, and high-profit leading companies in the construction industry, focusing on sectors like AI, controlled nuclear fusion, and low-altitude economy [8][10] Key Company Recommendations - Recommended companies include China Construction (dividend yield 5.29%), China Railway (dividend yield 4.81%), and China Communications Construction (dividend yield 3.39%), all of which are expected to benefit from stable growth and government investment [6][4] Macro/Meso/Micro Data Tables - The report includes various data tables that provide insights into the financial performance and projections of key construction companies, indicating a trend of improving cash flow and profitability in certain sectors [6][4] Infrastructure Investment Trends - The report predicts a significant increase in infrastructure investment, with a projected growth rate of 10.9% for broad infrastructure investment in 2025, driven by government policies and funding mechanisms [29][30]

Investment Rating - The report assigns an "Overweight" rating for the healthcare service industry [3]. Core Insights - The healthcare insurance fund's income showed stable growth in 2025, with a cumulative income of CNY 26,320.68 billion from January to November, reflecting a year-on-year increase of 2.9%. The income from urban employee insurance reached CNY 16,643.79 billion (+5.7%), while the income from rural resident insurance decreased by 1.6% to CNY 9,676.89 billion [2][4]. - The cumulative expenditure of the healthcare insurance fund from January to November was CNY 21,100.46 billion, marking a year-on-year increase of 0.5%. Urban employee insurance expenditure was CNY 12,033.33 billion (+2.4%), and rural resident insurance expenditure was CNY 9,067.14 billion (-1.9%) [4][9]. - The cumulative surplus of the healthcare insurance fund as of November 2025 was CNY 5,220.22 billion, with a surplus rate of 19.8%. The urban employee insurance fund had a surplus of CNY 4,610.46 billion (27.7%), while the rural resident insurance fund had a surplus of CNY 609.75 billion (6.3%) [4][9]. Summary by Sections Income and Expenditure - The healthcare insurance fund's income in November 2025 was CNY 2,800.58 billion, showing a month-on-month increase of 11.2%. The urban employee insurance fund's income was CNY 1,492.65 billion (+4.4%), and the rural resident insurance fund's income was CNY 1,307.92 billion (+20.1%) [9]. - The expenditure for November 2025 was CNY 2,064.22 billion, reflecting a year-on-year increase of 13.0%. Urban employee insurance expenditure was CNY 1,093.39 billion (+3.9%), and rural resident insurance expenditure was CNY 970.85 billion (+25.3%) [9]. Fiscal Health Expenditure - Cumulative health expenditure from the general public budget was CNY 18,687 billion from January to November 2025, with a year-on-year growth of 4.7%. The expenditure in November alone was CNY 1,810 billion, marking a significant increase of 32.5% [7][8].

Investment Rating - The report maintains an "Overweight" rating for the aviation and oil transportation sectors, indicating a positive outlook for both industries [35]. Core Insights - The aviation sector is expected to see robust demand growth, driven by increased travel during the New Year holiday, with significant year-on-year increases in both passenger volume and ticket prices. The report suggests a strategic investment during the off-peak season, anticipating a long-term super cycle [3][4]. - In the oil transportation sector, while seasonal price declines are noted, the report emphasizes the potential for future price increases due to ongoing global oil production growth and limited capacity expansion. It recommends a contrarian investment approach during the off-peak period [3][4]. Summary by Sections Aviation Sector - The report highlights a strong increase in travel demand during the New Year holiday, with a 19% year-on-year increase in overall passenger movement from December 31, 2025, to January 2, 2026. Specifically, civil aviation saw a 13% increase [3][4]. - Domestic ticket prices are estimated to rise by over 10% year-on-year during the holiday period, despite a projected short-term dip in passenger flow post-holiday [3][4]. - The aviation industry is experiencing high load factors while ticket prices remain at historical lows, suggesting a favorable environment for profitability growth driven by demand recovery and market pricing dynamics [3][4]. Oil Transportation Sector - The report notes that the average daily earnings for Very Large Crude Carriers (VLCC) reached $51,000 in 2025, significantly higher than the $36,000 in 2023-2024, driven by improved capacity utilization and increased oil production from the Middle East and South America [3][4]. - Despite a recent decline in freight rates during the traditional off-peak season, the report maintains a positive outlook for future price increases, supported by ongoing global oil production growth and limited fleet expansion [3][4]. - The report suggests monitoring geopolitical developments, particularly in Venezuela, and recommends increasing positions in companies like COSCO Shipping Energy, China Merchants Energy Shipping, and China Shipbuilding Leasing [3][4].

Quantitative Models and Construction Methods - **Model Name**: CSI 300 Enhanced Portfolio **Model Construction Idea**: The model aims to enhance the performance of the CSI 300 Index by leveraging quantitative strategies to generate excess returns over the benchmark[5][9][15] **Model Construction Process**: The portfolio is constructed by applying factor-based selection and weighting methodologies to the CSI 300 Index constituents. Factors such as valuation, growth, and momentum are utilized to optimize the portfolio's performance relative to the benchmark[15] **Model Evaluation**: The model demonstrates consistent excess returns over the CSI 300 Index, indicating its effectiveness in capturing alpha through quantitative strategies[15] - **Model Name**: CSI 500 Enhanced Portfolio **Model Construction Idea**: Similar to the CSI 300 Enhanced Portfolio, this model focuses on outperforming the CSI 500 Index by employing quantitative factor-based strategies[5][9][15] **Model Construction Process**: The portfolio is optimized using factors such as valuation and growth, applied to the CSI 500 Index constituents. The model aims to achieve a balance between risk and return while maintaining a low tracking error relative to the benchmark[15] **Model Evaluation**: The model shows moderate excess returns, though its performance is less consistent compared to the CSI 300 Enhanced Portfolio[15] - **Model Name**: CSI 1000 Enhanced Portfolio **Model Construction Idea**: This model targets excess returns over the CSI 1000 Index by leveraging quantitative factor-based strategies tailored to small-cap stocks[5][9][15] **Model Construction Process**: Factors such as momentum and growth are applied to the CSI 1000 Index constituents. The portfolio construction process emphasizes capturing the unique characteristics of small-cap stocks while managing risk[15] **Model Evaluation**: The model effectively captures alpha in the small-cap segment, with consistent excess returns over the benchmark[15] - **Model Name**: GARP Portfolio **Model Construction Idea**: The Growth at a Reasonable Price (GARP) strategy combines growth and valuation factors to identify stocks with strong growth potential at reasonable valuations[32] **Model Construction Process**: Stocks are selected based on a combination of growth metrics (e.g., earnings growth) and valuation metrics (e.g., price-to-earnings ratio). The portfolio is then optimized to balance growth and valuation characteristics[32] **Model Evaluation**: The GARP portfolio demonstrates strong long-term performance, though short-term results may vary depending on market conditions[32] - **Model Name**: Small-Cap Growth Portfolio **Model Construction Idea**: This model focuses on small-cap stocks with high growth potential, leveraging factors such as earnings growth and momentum[39] **Model Construction Process**: Stocks are selected from the small-cap universe based on growth and momentum factors. The portfolio is constructed to maximize exposure to these factors while managing risk[39] **Model Evaluation**: The portfolio shows strong performance in capturing growth opportunities in the small-cap segment, though it may be sensitive to market volatility[39] Model Backtesting Results - **CSI 300 Enhanced Portfolio**: - Weekly excess return: 0.19%[15] - Monthly excess return: 2.63%[15] - Annual excess return: 8.82%[15] - **CSI 500 Enhanced Portfolio**: - Weekly excess return: -0.10%[15] - Monthly excess return: -0.07%[15] - Annual excess return: 4.72%[15] - **CSI 1000 Enhanced Portfolio**: - Weekly excess return: 0.47%[15] - Monthly excess return: 0.96%[15] - Annual excess return: 4.67%[15] - **GARP Portfolio**: - Weekly excess return: -0.13%[32] - Monthly excess return: 1.53%[32] - Annual excess return: 23.51%[32] - **Small-Cap Growth Portfolio**: - Weekly excess return: 0.55%[39] - Monthly excess return: 5.00%[39] - Annual excess return: -6.37%[39] Quantitative Factors and Construction Methods - **Factor Name**: Market Capitalization (Size) **Factor Construction Idea**: This factor captures the performance difference between small-cap and large-cap stocks[42] **Factor Construction Process**: Stocks are ranked by market capitalization, and the top 10% (small-cap) and bottom 10% (large-cap) are selected to form long and short portfolios, respectively. The difference in returns between these portfolios represents the factor's performance[41][42] **Factor Evaluation**: The factor shows strong performance in favor of small-cap stocks, particularly in the short term[42] - **Factor Name**: Price-to-Book Ratio (PB) **Factor Construction Idea**: This valuation factor identifies undervalued stocks based on their book value relative to market price[42] **Factor Construction Process**: Stocks are ranked by PB ratio, and the top 10% (low PB) and bottom 10% (high PB) are selected to form long and short portfolios, respectively. The difference in returns between these portfolios represents the factor's performance[41][42] **Factor Evaluation**: The factor's performance is mixed, with periods of underperformance in certain market conditions[42] - **Factor Name**: Return on Equity (ROE) **Factor Construction Idea**: This profitability factor identifies companies with high returns on equity, indicating efficient use of capital[53] **Factor Construction Process**: Stocks are ranked by ROE, and the top 10% (high ROE) and bottom 10% (low ROE) are selected to form long and short portfolios, respectively. The difference in returns between these portfolios represents the factor's performance[41][53] **Factor Evaluation**: The factor demonstrates consistent positive returns, particularly in the long term[53] Factor Backtesting Results - **Market Capitalization (Size)**: - Weekly long-short return: 0.20%[42] - Monthly long-short return: -6.40%[42] - Annual long-short return: 45.24%[43] - **Price-to-Book Ratio (PB)**: - Weekly long-short return: -0.45%[42] - Monthly long-short return: -1.51%[42] - Annual long-short return: -12.78%[43] - **Return on Equity (ROE)**: - Weekly long-short return: 0.65%[53] - Monthly long-short return: 4.49%[53] - Annual long-short return: 2.82%[54]